Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Etodolac

41340-25-4C17H21NO3287.359 g/mol

A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number41340-25-4ChEBI ↗
Molecular formulaC17H21NO3ChEBI ↗
Molar mass287.359 g/molChEBI ↗
Monoisotopic mass287.15214 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:4909ChEBI ↗

Cross-source molecular data

PubChem
Molar mass287.35 g/molPubChem ↗
Exact mass287.15214353 DaPubChem ↗
Computed XLogP2.8PubChem ↗
Topological polar surface area (Ų)62.3PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors3PubChem ↗
Rotatable bonds4PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
etodolac
(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
NNYBQONXHNTVIJ-UHFFFAOYSA-N
CCc1cccc2c3c(nc12)C(CC)(CC(=O)O)OCC3
InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)

Names & synonyms

(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acidetodolacoetodolacum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

non-steroidal anti-inflammatory druganalgesicnon-narcotic analgesicantipyreticantineoplastic agentantirheumatic drugcyclooxygenase 2 inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00347997 mol

Uses 287.359 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 17 atoms
71.06%
O
Oxygen · 3 atoms
16.70%
H
Hydrogen · 21 atoms
7.37%
N
Nitrogen · 1 atom
4.87%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints. ↗Journal of medicinal chemistry · 2004 Sep 23 · PMID 15369391
DE2301525 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3939178 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:4909

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 3308 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.